MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 103 filers reported holding MAXCYTE INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,348,103 | -60.7% | 1,073,110 | -42.2% | 0.32% | -52.4% |
| Q2 2023 | $8,526,228 | +26.3% | 1,857,566 | +36.2% | 0.67% | +9.9% |
| Q1 2023 | $6,752,899 | -9.4% | 1,364,222 | -0.1% | 0.61% | -12.1% |
| Q4 2022 | $7,454,773 | -15.8% | 1,365,343 | +0.2% | 0.69% | -22.8% |
| Q3 2022 | $8,857,000 | +41.9% | 1,362,543 | +3.3% | 0.90% | +23.4% |
| Q2 2022 | $6,241,000 | -32.4% | 1,319,489 | -0.1% | 0.73% | -10.9% |
| Q1 2022 | $9,237,000 | -26.4% | 1,321,406 | +7.2% | 0.82% | -9.3% |
| Q4 2021 | $12,557,000 | +3.4% | 1,232,277 | +23.9% | 0.90% | +12.4% |
| Q3 2021 | $12,145,000 | – | 994,670 | – | 0.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,885,000 | $5,881,200 | 5.55% |
| Vitruvian Partners LLP | 5,043,356 | $15,735,271 | 4.46% |
| Stonepine Capital Management, LLC | 3,761,640 | $11,736,317 | 3.90% |
| Mudita Advisors LLP | 1,390,858 | $4,339,477 | 3.17% |
| RIVER GLOBAL INVESTORS LLP | 1,473,254 | $4,588,359 | 1.07% |
| Casdin Capital, LLC | 1,890,000 | $5,896,800 | 0.65% |
| Portolan Capital Management | 2,143,666 | $6,688,238 | 0.62% |
| Grandeur Peak Global Advisors, LLC | 1,434,819 | $4,476,635 | 0.34% |
| First Light Asset Management, LLC | 1,073,110 | $3,348,103 | 0.32% |
| Granahan Investment Management | 1,975,847 | $6,164,643 | 0.22% |